These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 36481298

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
    Li YY, Liang YD, Yao SM, Zheng PP, Zeng XZ, Cui LL, Guo D, Wang H, Yang JF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug 24; 48(8):661-668. PubMed ID: 32847322
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Preoperative NT-proBNP and LVEF for the prediction of acute kidney injury after noncardiac surgery: a single-centre retrospective study.
    Wang J, Dong Y, Zhao B, Liu K.
    BMC Anesthesiol; 2022 Jun 24; 22(1):196. PubMed ID: 35751021
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy.
    Kaufmann BA, Goetschalckx K, Min SY, Maeder MT, Bucher U, Nietlispach F, Bernheim AM, Pfisterer ME, Brunner-La Rocca HP, TIME-CHF investigators.
    Int J Cardiol; 2015 Jul 15; 191():286-93. PubMed ID: 25981371
    [Abstract] [Full Text] [Related]

  • 47. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
    Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B, SOCRATES-REDUCED Investigators and Coordinators.
    JAMA; 2015 Dec 01; 314(21):2251-62. PubMed ID: 26547357
    [Abstract] [Full Text] [Related]

  • 48. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
    Wang F, Xu ZM, Wang L, Bian WY, Jia X, Duan B, Li W, Li YS.
    Zhonghua Nei Ke Za Zhi; 2005 Jul 01; 44(7):490-4. PubMed ID: 16080835
    [Abstract] [Full Text] [Related]

  • 49. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.
    Gundogdu F, Bozkurt E, Kiziltunc A, Sevimli S, Arslan S, Gurlertop Y, Senocak H, Karakelleoglu S.
    Echocardiography; 2007 Feb 01; 24(2):113-7. PubMed ID: 17313541
    [Abstract] [Full Text] [Related]

  • 50. Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure.
    Alvi RM, Zanni MV, Neilan AM, Hassan MZO, Tariq N, Zhang L, Afshar M, Banerji D, Mulligan CP, Rokicki A, Awadalla M, Januzzi JL, Neilan TG.
    Clin Infect Dis; 2020 Aug 22; 71(5):1306-1315. PubMed ID: 31740919
    [Abstract] [Full Text] [Related]

  • 51. Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction.
    Azzo JD, Dib MJ, Zagkos L, Zhao L, Wang Z, Chang CP, Ebert C, Salman O, Gan S, Zamani P, Cohen JB, van Empel V, Richards AM, Javaheri A, Mann DL, Rietzschel ER, Schafer PH, Seiffert DA, Gill D, Burgess S, Ramirez-Valle F, Gordon DA, Cappola TP, Chirinos JA.
    Circ Heart Fail; 2024 Feb 22; 17(2):e011146. PubMed ID: 38299345
    [Abstract] [Full Text] [Related]

  • 52. The Relation Between Global Longitudinal Strain and Serum Natriuretic Peptide Is More Strict Than That Found Between the Latter and Left Ventricular Ejection Fraction: A Retrospective Study in Chronic Heart Failure.
    De Vecchis R, Baldi C, Di Biase G.
    J Clin Med Res; 2015 Dec 22; 7(12):979-88. PubMed ID: 26566412
    [Abstract] [Full Text] [Related]

  • 53. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G, Hage C, Orsini N, Dahlström U, Perrone-Filardi P, Rosano GM, Lund LH.
    Circ Heart Fail; 2016 Nov 22; 9(11):. PubMed ID: 28029640
    [Abstract] [Full Text] [Related]

  • 54. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL, Qiu YR, Zhou F, Feng PF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 22; 28(5):866-9. PubMed ID: 18504223
    [Abstract] [Full Text] [Related]

  • 55. N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction.
    Januzzi JL, Tan X, Yang L, Brady JE, Yang M, Banka P, Lautsch D.
    ESC Heart Fail; 2022 Feb 22; 9(1):87-99. PubMed ID: 34918487
    [Abstract] [Full Text] [Related]

  • 56. Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Myhre PL, Vaduganathan M, Claggett BL, Miao ZM, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Lindholm D, Petersson M, Langkilde AM, McMurray JJV, Solomon SD.
    JACC Heart Fail; 2022 Dec 22; 10(12):902-913. PubMed ID: 36114137
    [Abstract] [Full Text] [Related]

  • 57. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY, Lee SY, Tsai WC, Lin CY, Shieh MD, Ciou DS.
    ESC Heart Fail; 2020 Oct 22; 7(5):2672-2678. PubMed ID: 32613707
    [Abstract] [Full Text] [Related]

  • 58. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG.
    Eur J Heart Fail; 2009 Apr 22; 11(4):367-77. PubMed ID: 19179406
    [Abstract] [Full Text] [Related]

  • 59. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
    Rørth R, Jhund PS, Kristensen SL, Desai AS, Køber L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.
    Eur J Heart Fail; 2019 Jan 22; 21(1):40-49. PubMed ID: 30537261
    [Abstract] [Full Text] [Related]

  • 60. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL, Mogensen UM, Jhund PS, Rørth R, Anand IS, Carson PE, Desai AS, Pitt B, Pfeffer MA, Solomon SD, Zile MR, Køber L, McMurray JJV.
    Circ Heart Fail; 2019 Mar 22; 12(3):e005766. PubMed ID: 30871349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.